NCT02790424

Brief Summary

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 22, 2013

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

May 12, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 3, 2016

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2021

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

8 years

First QC Date

May 12, 2016

Last Update Submit

November 8, 2022

Conditions

Neurological Diseases

Outcome Measures

Primary Outcomes (4)

  • Magnetic brain activity

    MEG records

    2 hours

  • Brain imaging

    MRI and SPECT-CT records

    2 hours

  • Electrical brain activity

    EEG records

    2 hours

  • Motor activity parameters

    Motor platform records

    2 hours

Study Arms (1)

Patients

EXPERIMENTAL

Imaging devices

Device: Imaging devices

Interventions

Imaging devicesDEVICE

technological adjustment tests

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteers patient
  • Male or female aged over 18 years
  • Registered in the French social security scheme
  • Signed informed consent

You may not qualify if:

  • Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG)
  • Contraindication to Magnetic resonance imaging (MRI)
  • All categories of protected persons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CLINATEC

Grenoble, 38000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2016

First Posted

June 3, 2016

Study Start

October 22, 2013

Primary Completion

October 22, 2021

Study Completion

October 22, 2021

Last Updated

November 14, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)